MASS 908devices.com: Forward P/S Multiple

Graphic logo of 908 Devices Corp (MASS)

The synergy between the electronic engineering team and the demand for compact mass spectrometers in laboratories determines the market value of 908 Devices Inc. (MASS). The expected P/S trend captures these processes, with 6.10 representing the latest level. Simultaneously, the company is expanding into environmental monitoring, developing instruments for the rapid analysis of water and air pollution while adhering to waste disposal standards.

908devices.com - MASS Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for 908 Devices Corporation (MASS)

- current price and projected stock value:
Stock Price 908 Devices|MASS - Average Forecast Price
- company stock capitalization data:
Market Capitalization 908 Devices Corporation|MASS - Business Value
- issuer book value statistics:
Book Value per Share 908 Devices|MASS - Book Valuation of Business|Market Capitalization to Book Value Ratio 908devices.com|MASS - Cumulative Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital 908 Devices Inc.|MASS - Long-Term Debt to Capital|Short-Term Debt to Equity 908 Devices Inc.|MASS - Company Debts|Debt to Book Value 908 Devices Corporation|MASS - Company Long-Term Loans and Borrowings|Company Short-Term Debts 908 Devices|Quick Liquidity 908devices.com
- financial results and valuation multiples details:
MASS - Annual Net Income|Future Profit 908 Devices Inc.|MASS - P/E Multiple|Forward P/E Multiple 908 Devices Corp|MASS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 908 Devices Corporation|MASS - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months 908 Devices|MASS - Net earnings per share for the last 12 months|Quarterly EPS earnings growth 908devices.com|MASS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year 908 Devices Inc.
- sales volume and revenue indicators:
MASS - Company Sales Volume|Company Future Sales Volume 908 Devices|MASS - Market Cap to Sales Volume|Market Cap to Expected Sales Ratio 908 Devices Corporation
Summary company analytics:908 Devices (MASS)
Product sample of 908 Devices Inc.

The assessment of the margin of safety for 908 Devices Inc. (MASS) is based on the forward P/S ratio, which compares current market capitalization with expected sales volume, allowing investors to filter out price volatility and determine the real value of a unit of future revenue. When analyzing the forward P/S ratio, it is essential to consider that US export restrictions on microelectronics narrow target markets, directly limiting revenue growth potential and overstating the multiple.

Key competitors

Forward P/S Multiple ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Market Cap to Future Revenue Ratio|GE Healthcare Corp - Forward P/S Multiple|MTD (Mettler Toledo Inc) - Market Cap to Projected Revenue|WAT: Forward P/S Multiple|TECH - Market Cap to Expected Sales Ratio|BRKR (Bruker) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Azenta Inc (AZTA)|Forward P/S Multiple VREX|Forward P/S Multiple Semler (SMLR)|Price-to-Projected Revenue Ratio Butterfly Network, Inc. BFLY|mesalabs.com - Price-to-Projected Revenue Ratio|QSI: Forward Price-to-Revenue Multiple|Forward Price to Sales NNOX (Nano-X Imaging)|QTRX: Forward P/S Multiple|Market Cap to Future Revenue Ratio CapsoVision (CV)|Price-to-Projected Revenue Ratio MaxCyte, Inc.|RPID - Projected Price to Revenue|Forward Price-to-Revenue Multiple SEER (Seer)|Forward P/S Multiple Hyperfine Inc (HYPR)|Forward P/S Multiple FONR (FONAR Corp)|Market Cap to Expected Sales Ratio Daxor Corp (DXR)|MDAI - Price-to-Projected Revenue Ratio|Future Price to Revenue VIVS|Aclarion, Inc. (ACON) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Talis Biomedical Corp TLIS|Price-to-Projected Revenue Ratio T2 Biosystems, Inc. (TTOO)